WELCOME TO iNANOD
AI-BACKED RAPID TARGETED CANCER CHEMO-IMMUNOTHERAPY
WHAT WE DO
.png)
At iNANOD, we use nanotechnology to make cancer treatment smarter and more effective. Our platform should not just deliver medication more accurately; it is also to stimulate a targeted immune response directly at the tumor site. Based on modern research results, it is our ambition—and we firmly believe it is achievable—to bridge the gap between laboratory innovation and clinical success. By maximizing the power of chemotherapy, nano-biotechnology and empowering the body's natural defences, we are dedicated to creating a lasting impact on global healthcare.
ABOUT
iNANOD AS is a high-growth micro-pharma pioneer within the Oslo Cancer Cluster, redefining oncology with a "double-hit" platform that synchronizes high-precision, faster chemotherapy along with advanced immunotherapy. We're working to improve treatment efficacy by increasing the percentage of the injected dose (ID%) reaching inside the solid malignant tumour. We aim to increase ID% from the industry average of 1% to 20%.
After successful in silico studies, we're moving to clinical proof-of-principle studies, marking our transition to a high-value development phase. With our next major valuation milestone approaching, the window for early-stage participation is narrowing. Partner with us today to lead the future of cancer care. Want to support?
THE PEOPLE
BOARD MEMBERS
Åge Nærdal
Chairman
Trained as a Pharmacist having more than 35 years of experience in leadership from pharmaceutical industry.
Stener Kvinnsland
Board member
MD with a PhD in oncology. Various roles in the pharmaceutical an biotech industry, former COB at Oslo University Hospital, former MD of Helse Bergen and former Director at Haukeland University Hospital. Specialist and professor in cancer medicine.
Per Foss
Board member
Bio-organic chemistry doctorate having hugely diverse professional expertise in the industry.
Nalinava Sengupta
Board Member & CEO
After 15 years of academic research in chemistry, turned entrepreneur for a mission.
Thomas Due
Board member
He has over 20 years of Innovation and Venture Capital Fundraising experience in Norway. He has spent most of his adult life working where finance meets entrepreneurs.
SUPPORTERS
MEMBER OF
